MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 25, 2007; DOI: 10.1124/mol.107.038810


0026-895X/07/7206-1657-1664$20.00
Mol Pharmacol 72:1657-1664, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.107.038810v1
mol.107.038810v2
72/6/1657    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moussaieff, A.
Right arrow Articles by Mechoulam, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moussaieff, A.
Right arrow Articles by Mechoulam, R.

Incensole Acetate, a Novel Anti-Inflammatory Compound Isolated from Boswellia Resin, Inhibits Nuclear Factor-{kappa}B ActivationFormula

Arieh Moussaieff, Esther Shohami, Yoel Kashman, Ester Fride, M. Lienhard Schmitz, Florian Renner, Bernd L. Fiebich, Eduardo Munoz, Yinon Ben-Neriah, and Raphael Mechoulam

Department of Medicinal Chemistry and Natural Products, Medical Faculty (A.M, R.M.) and Department of Pharmacology and Experimental Therapeutics, School of Pharmacy (A.M., E.S.), Hebrew University, Jerusalem, Israel; School of Chemistry, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel-Aviv University, Israel (Y.K.); Departments of Behavioral Sciences and Molecular Biology, the College of Judea and Samaria, Ariel, Israel (E.F.); Institute of Biochemistry, Medical Faculty, Justus-Liebig-University, Giessen, Germany (M.L.S., F.R.); University of Freiburg Medical School, Department of Psychiatry, Germany (B.L.F.); Departamento Biologia Celular, Fisiologia e Inmunologia, Facultad de Medicina, Universidad de Cordoba, Spain (E.M.); and the Lautenberg Center for Immunology, Hebrew University-Hadassah Medical School, Jerusalem, Israel (Y.B.)

Boswellia resin is a major anti-inflammatory agent in herbal medical tradition, as well as a common food supplement. Its anti-inflammatory activity has been attributed to boswellic acid and its derivatives. Here, we re-examined the anti-inflammatory effect of the resin, using inhibitor of nuclear factor-{kappa}B{alpha} (I{kappa}B{alpha}) degradation in tumor necrosis factor (TNF) {alpha}-stimulated HeLa cells for a bioassay-guided fractionation. We thus isolated two novel nuclear factor-{kappa}B (NF-{kappa}B) inhibitors from the resin, their structures elucidated as incensole acetate (IA) and its nonacetylated form, incensole (IN). IA inhibited TAK/TAB-mediated I{kappa}B kinase (IKK) activation loop phosphorylation, resulting in the inhibition of cytokine and lipopolysaccharide-mediated NF-{kappa}B activation. It had no effect on IKK activity in vitro, and it did not suppress I{kappa}B{alpha} phosphorylation in costimulated T-cells, indicating that the kinase inhibition is neither direct nor does it affect all NF-{kappa}B activation pathways. The inhibitory effect seems specific; IA did not interfere with TNF{alpha}-induced activation of c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase. IA treatment had a robust anti-inflammatory effect in a mouse inflamed paw model. Cembrenoid diterpenoids, specifically IA and its derivatives, may thus constitute a potential novel group of NF-{kappa}B inhibitors, originating from an ancient anti-inflammatory herbal remedy.


Received for publication June 6, 2007.

Accepted for publication September 6, 2007.

Address correspondence to: Arieh Moussaieff, Department of Medicinal Chemistry and Natural Products, Medical Faculty, Hebrew University, Jerusalem 91120, Israel. E-mail: ariehm{at}ekmd.huji.ac.il




This article has been cited by other articles:


Home page
FASEB J.Home page
A. Moussaieff, N. Rimmerman, T. Bregman, A. Straiker, C. C. Felder, S. Shoham, Y. Kashman, S. M. Huang, H. Lee, E. Shohami, et al.
Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain
FASEB J, August 1, 2008; 22(8): 3024 - 3034.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics